ASCO22 - Highlights melanoom en niercelcarcinoom

Koos van der Hoeven bespreekt met John Haanen onder andere de resultaten van de Nederlandse PRADO-trial gepresenteerd door Christian Blank, de KEYNOTE-716- en de NeoTrio-studie bij melanoom. Daarnaast bespreken zij belzutifan, de KEYNOTE-564- en de CALYPSO-studie bij niercelcarcinoom.

Episode metadata supplied by the publisher feed · Published Jun 10, 2022

Embed this episode

Attribution link and audio player

Ready to play

ASCO22 - Highlights melanoom en niercelcarcinoom

0:00 33:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncologie.nu?

This episode is 33 minutes long.

When was this Oncologie.nu episode published?

This episode was published on June 10, 2022.

Can I download this Oncologie.nu episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!